325 related articles for article (PubMed ID: 16362159)
1. Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis.
Otsuka Y; Nakayama M; Ikeda M; Sherif AM; Yokoyama K; Yamamoto H; Kawaguchi Y
Clin Exp Nephrol; 2005 Dec; 9(4):315-319. PubMed ID: 16362159
[TBL] [Abstract][Full Text] [Related]
2. High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment.
Yamamoto R; Nakayama M; Hasegawa T; Miwako N; Yamamoto H; Yokoyami K; Ikeda M; Kato N; Hayakawa H; Takahashi H; Otsuka Y; Kawaguchi Y; Hosoya T
Adv Perit Dial; 2002; 18():131-4. PubMed ID: 12402604
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment.
Yamamoto R; Otsuka Y; Nakayama M; Maruyama Y; Katoh N; Ikeda M; Yamamoto H; Yokoyama K; Kawaguchi Y; Matsushima M
Clin Exp Nephrol; 2005 Jun; 9(2):148-52. PubMed ID: 15980950
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and preventive measures for encapsulating peritoneal sclerosis--Jikei experience 2002.
Nakayama M; Yamamoto H; Ikeda M; Hasegawa T; Kato N; Takahashi H; Otsuka Y; Yokoyama K; Yamamoto R; Kawaguchi Y; Hosoya T
Adv Perit Dial; 2002; 18():144-8. PubMed ID: 12402607
[TBL] [Abstract][Full Text] [Related]
5. [Long-standing high-transport membrane as a risk factor for EPS development after PD withdrawal: an analysis based on changes in peritoneal function during and after CAPD withdrawal].
Nakayama M; Ikeda M; Katoh N; Hayakawa H; Numata M; Otsuka Y; Yamamoto R; Yamamoto H; Yokoyama K; Kubo H; Kawaguchi Y; Hosoya T
Nihon Jinzo Gakkai Shi; 2002 May; 44(4):396-401. PubMed ID: 12073625
[TBL] [Abstract][Full Text] [Related]
6. Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure.
Summers AM; Clancy MJ; Syed F; Harwood N; Brenchley PE; Augustine T; Riad H; Hutchison AJ; Taylor P; Pearson R; Gokal R
Kidney Int; 2005 Nov; 68(5):2381-8. PubMed ID: 16221244
[TBL] [Abstract][Full Text] [Related]
7. Clinical risk factors and outcomes of massive ascites accumulation after discontinuation of peritoneal dialysis.
Chang MS; Chen NC; Hsu CY; Huang CW; Lee PT; Chou KJ; Fang HC; Chen CL
Ren Fail; 2020 Nov; 42(1):1-9. PubMed ID: 31826694
[No Abstract] [Full Text] [Related]
8. Impact of combination therapy with peritoneal dialysis and hemodialysis on peritoneal function.
Moriishi M; Kawanishi H; Tsuchiya S
Adv Perit Dial; 2010; 26():67-70. PubMed ID: 21348383
[TBL] [Abstract][Full Text] [Related]
9. Preservation of peritoneal catheter for prevention of encapsulating peritoneal sclerosis.
Moriishi M; Kawanishi H; Kawai T; Takahashi S; Hirai T; Shishida M; Watanabe H; Takahashi N
Adv Perit Dial; 2002; 18():149-53. PubMed ID: 12402608
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for encapsulating peritoneal sclerosis: Analysis of a 36-year experience in a University Hospital.
Nakao M; Yamamoto I; Maruyama Y; Morishita M; Nakashima A; Matsuo N; Tanno Y; Ohkido I; Ikeda M; Yamamoto H; Yokoyama K; Yokoo T
Nephrology (Carlton); 2017 Nov; 22(11):907-912. PubMed ID: 27556577
[TBL] [Abstract][Full Text] [Related]
11. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
12. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
[TBL] [Abstract][Full Text] [Related]
13. Proof-of-principle study to detect metabolic changes in peritoneal dialysis effluent in patients who develop encapsulating peritoneal sclerosis.
Dunn WB; Summers A; Brown M; Goodacre R; Lambie M; Johnson T; Wilkie M; Davies S; Topley N; Brenchley P
Nephrol Dial Transplant; 2012 Jun; 27(6):2502-10. PubMed ID: 22294777
[TBL] [Abstract][Full Text] [Related]
14. Dialysate CA125 levels in children on continuous peritoneal dialysis.
Turhan P; Sever L; Caliskan S; Kasapcopur O; Sever A; Hacibekiroglu M; Arisoy N
Pediatr Nephrol; 2005 Nov; 20(11):1615-21. PubMed ID: 16133054
[TBL] [Abstract][Full Text] [Related]
15. Serum beta2 microglobulin (beta2MG) level is a potential predictor for encapsulating peritoneal sclerosis (EPS) in peritoneal dialysis patients.
Yokoyama K; Yoshida H; Matsuo N; Maruyama Y; Kawamura Y; Yamamoto R; Hanaoka K; Ikeda M; Yamamoto H; Nakayama M; Kawaguchi Y; Hosoya T
Clin Nephrol; 2008 Feb; 69(2):121-6. PubMed ID: 18218305
[TBL] [Abstract][Full Text] [Related]
16. Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group.
Shroff R; Stefanidis CJ; Askiti V; Edefonti A; Testa S; Ekim M; Kavaz A; Ariceta G; Bakkaloglu S; Fischbach M; Klaus G; Zurowska A; Holtta T; Jankauskiene A; Vondrak K; Vande Walle J; Schmitt CP; Watson AR;
Nephrol Dial Transplant; 2013 Jul; 28(7):1908-14. PubMed ID: 23348882
[TBL] [Abstract][Full Text] [Related]
17. Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature.
Afthentopoulos IE; Passadakis P; Oreopoulos DG; Bargman J
Adv Ren Replace Ther; 1998 Jul; 5(3):157-67. PubMed ID: 9686626
[TBL] [Abstract][Full Text] [Related]
18. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E
Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal dialysis patients with high effluent fibrin degradation products.
Moriishi M; Kawanishi H; Tsuchiya S
Adv Perit Dial; 2009; 25():41-4. PubMed ID: 19886315
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients.
Alatab S; Najafi I; Pourmand G; Hosseini M; Shekarchian S
Ren Fail; 2017 Nov; 39(1):32-39. PubMed ID: 27774831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
